Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dl-3-n-butylphthalide for acute ischemic stroke
ChiCTR-IPR-16010051Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of butylphthalide in ischemic stroke (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: rLMC score, CBF and 3 more. Started Dec 2016; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-IPR-16010051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16010051.